Intuitive Surgical, Inc. (NASDAQ:ISRG)‘s stock had its “hold” rating reiterated by Royal Bank Of Canada in a research note issued to investors on Friday. They presently have a $1,000.00 target price on the medical equipment provider’s stock. Royal Bank Of Canada’s price objective suggests a potential upside of 7.82% from the stock’s current price.
ISRG has been the topic of a number of other reports. Zacks Investment Research raised Intuitive Surgical from a “hold” rating to a “buy” rating and set a $911.00 price target on the stock in a report on Monday, April 24th. Canaccord Genuity reaffirmed a “buy” rating and set a $800.00 price target on shares of Intuitive Surgical in a report on Friday, March 24th. Barclays PLC reaffirmed a “buy” rating and set a $800.00 price target on shares of Intuitive Surgical in a report on Sunday, March 26th. Wedbush upped their price target on Intuitive Surgical from $835.00 to $875.00 and gave the company an “outperform” rating in a report on Monday, April 24th. Finally, Leerink Swann reaffirmed an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, July 5th. Seven investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $939.27.
Shares of Intuitive Surgical (ISRG) traded down 4.55% during midday trading on Friday, hitting $927.47. The stock had a trading volume of 1,024,610 shares. The stock’s 50-day moving average is $934.93 and its 200-day moving average is $803.42. Intuitive Surgical has a 12 month low of $610.71 and a 12 month high of $974.66. The stock has a market cap of $34.17 billion, a PE ratio of 46.75 and a beta of 0.39.
Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.79 by $0.16. The firm had revenue of $756.20 million for the quarter, compared to the consensus estimate of $724.51 million. Intuitive Surgical had a return on equity of 15.51% and a net margin of 28.44%. The company’s quarterly revenue was up 12.8% on a year-over-year basis. During the same period in the prior year, the company posted $5.62 earnings per share. Equities analysts anticipate that Intuitive Surgical will post $23.59 EPS for the current year.
In other Intuitive Surgical news, Director Mark J. Rubash sold 3,000 shares of the company’s stock in a transaction dated Thursday, June 8th. The stock was sold at an average price of $931.51, for a total value of $2,794,530.00. Following the completion of the sale, the director now owns 4,151 shares in the company, valued at $3,866,698.01. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Alan J. Levy sold 1,386 shares of the company’s stock in a transaction dated Monday, April 24th. The stock was sold at an average price of $813.15, for a total value of $1,127,025.90. Following the completion of the sale, the director now owns 2,598 shares of the company’s stock, valued at approximately $2,112,563.70. The disclosure for this sale can be found here. In the last 90 days, insiders sold 28,041 shares of company stock valued at $24,493,708. Company insiders own 2.50% of the company’s stock.
Hedge funds have recently modified their holdings of the company. Guardian Life Insurance Co. of America boosted its stake in shares of Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock worth $109,000 after buying an additional 3 shares during the last quarter. Acropolis Investment Management LLC acquired a new stake in Intuitive Surgical during the first quarter valued at about $115,000. D. Scott Neal Inc. acquired a new stake in Intuitive Surgical during the second quarter valued at about $120,000. Parallel Advisors LLC boosted its stake in Intuitive Surgical by 10.1% in the first quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock valued at $129,000 after buying an additional 14 shares in the last quarter. Finally, Huntington National Bank boosted its stake in Intuitive Surgical by 14.1% in the first quarter. Huntington National Bank now owns 170 shares of the medical equipment provider’s stock valued at $130,000 after buying an additional 21 shares in the last quarter. Institutional investors and hedge funds own 97.53% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
